Mexico makes genomics R&D (research and development) a top priority:
This article was originally published in Clinica
Mexico has pledged to put genomics at the top of its healthcare research modernisation agenda. At a recent symposium on the future of genomics in medicine, health minister Dr Julio Frenk Mora said that the current national healthcare research strategy sets out guarantees for funding in this area. He also announced that the establishment of the national genomics medicine institute is now subject only to the approval of congress. If approved, it will become the 11th national healthcare institute of the Mexican health service, the SSA.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.